(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HANCHORBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

HANCHORBIO

ST13

US500000090772552

Class

5, 35, 42

Filing

90772552

Registration

7003113

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

03/21/2023

Trademark type

Combined

Nice classes

5, 35, 42

Filing date

06/14/2021

Registration date

03/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/21/2023

Last transaction

03/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

16

Owner location

Taipei City, TW

Examiner

KUYKENDALL, LYNDSEY

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "HanchorBio" in stylized blue font below three interconnected designs comprised of three interconnected circular designs each, in bright blue, orange and light green. Beneath the interconnected circular design is a grey oval shadow.

Holders and representatives

Holders

HanchorBio Inc.

Representatives

Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.

Technical classification

Nice Classes

Class 5Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products and medicines for the treatment of cancers or autoimmune diseases for human use; Reagents for medical diagnostics; Therapeutic reagents for promoting hair growth; Vaccines for human use; Pharmaceutical reagents for medical useto enhance immunity; Anti-cancer reagents and medicines; Image-forming reagents for medical diagnostics; Western medicines for treating cancers or autoimmune diseases; Chinese medicines for treating cancers or autoimmune diseases; Anti-viral reagents and medicines for treating cancers or autoimmune diseases; Biological reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Protein reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Chemical reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Biological tissue culture reagents for medical therapeutic use for the treatment of cancers or autoimmune diseases; Testing chemicals for medical therapeutic use for the treatment of cancers or autoimmune diseases; Diagnostic reagents for medical therapeutic use; Biomarker diagnostic reagents for medical therapeutic use; Nutritional supplements; Biological reagents for veterinary use

Class 35

retail and wholesale store services featuring pharmaceutical products; retail and wholesale store services featuring western medicines; retail and wholesale store services featuring Chinese medicines; retail and wholesale store services featuring nutritional supplements; retail and wholesale store services featuring medical equipment

Class 42

Providing services for biomedical research and developmentproducing biological medicines; Biological research; Bacteriological research; Providing experimental medicines sample testing and diagnostic services for others for clinical research purposes; Providing reagent sample testing and diagnostic services for others for clinical research purposes; Clinical testing of pharmaceutical medicines for others; Scientific research and analysis of experimental medicines or reagents; Medical research; Product research and development on behalf of other parties; Technical research in the field of pharmaceutical studies; Research for technological programs in the nature of biological drug design; Technical writingwriting of technological documents; industrial analysis and research services; Rental of laboratory equipment for experiments; Service for scientific laboratories; Scientific research; Technological consultancy in the field of biological protein engineering; Scientific research in the field of biological/biomedical protein design and engineering; technical research in the field of biological/biomedical protein design and engineering

Publications

History of USPTO decisions and trademark events.

30 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/21/2023

ISPO

WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST

01/19/2023

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

01/17/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/03/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

01/03/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/03/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/03/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/03/2023

PUBO

PUBLISHED FOR OPPOSITION

01/03/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/14/2022

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/29/2022

ALIE

ASSIGNED TO LIE

11/22/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/15/2022

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

11/15/2022

DMCC

DATA MODIFICATION COMPLETED

11/15/2022

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

10/13/2022

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

05/06/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/03/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/07/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/07/2022

ALIE

ASSIGNED TO LIE

04/04/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/31/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/08/2022

GNRT

NON-FINAL ACTION E-MAILED

03/08/2022

CNRT

NON-FINAL ACTION WRITTEN

03/08/2022

DOCK

ASSIGNED TO EXAMINER

03/03/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/02/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/01/2021

NWAP

NEW APPLICATION ENTERED

06/17/2021

Continuous trademark protection

Get notified about every new filing that threatens HANCHORBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.